• Thu, August 8, 2024

William Plovanic Initiated (TNDM) at Strong Buy and Held Target at $57 on, Aug 8th, 2024

William Plovanic of Canaccord Genuity, Initiated "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy and Held Target at $57 on, Aug 8th, 2024.

William has made no other calls on TNDM in the last 4 months.



There are 10 other peers that have a rating on TNDM. Out of the 10 peers that are also analyzing TNDM, 1 agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Increased Target to $39 on, Friday, August 2nd, 2024


These are the ratings of the 9 analyists that currently disagree with William


  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $58 on, Monday, August 5th, 2024
  • Matt O'Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $55 on, Friday, August 2nd, 2024
  • Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $58 on, Monday, June 10th, 2024
  • Issie Kirby of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $60 on, Thursday, May 30th, 2024
  • Mathew Blackman of "Stifel" Maintained at Strong Buy with Increased Target to $60 on, Wednesday, May 29th, 2024
  • Brooks O'Neil of "Lake Street" Maintained at Strong Buy with Increased Target to $75 on, Wednesday, May 22nd, 2024
  • Joanne Wuensch of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $57 on, Wednesday, May 22nd, 2024
  • Mike Kratky of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $45 on, Thursday, April 25th, 2024

Like: 👍